A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
Krystal Biotech, Inc.
Study ID
NCT06563414
Status
Recruiting
Apply to this trial

Conditions

  • Epidermolysis Bullosa Dystrophica
  • Epidermolysis Bullosa Dystrophica Dominans
  • Epidermolysis Bullosa Dystrophica, Recessive

Eligibility Criteria

Sex
ALL
Age
6 Months - N/A
Healthy Volunteers
Not accepted

Study Details

This study is a non-interventional, observational study that will evaluate the natural history of corneal abrasions in patients with Dystrophic Epidermolysis Bullosa (DEB).

Key Dates

Start date
Aug 2, 2024
Status verified
Jul 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Corneal abrasion frequency [ Time Frame: Baseline through up to 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Krystal BiotechPittsburghPennsylvania15203
Brittani Agostini
[email protected]
412-586-5830

Find similar trials in Pittsburgh, PA

By research site
Krystal Biotech· Pittsburgh, PA

Related Studies